Some neurodevelopment-related pathways, such as mitogen-activated protein kinase (MAPK) signaling pathway, focal adhesion, and so on, were not changed in the VPA-induced autism model group but remarkably upregulated after AVP treatment (Figures 10A–F). The gene discussed is WNK2; the disease is autism.